PAVmed Inc
NASDAQ:PAVM

Watchlist Manager
PAVmed Inc Logo
PAVmed Inc
NASDAQ:PAVM
Watchlist
Price: 0.5818 USD -1.89% Market Closed
Market Cap: 10.3m USD

Net Margin
PAVmed Inc

3 635.2%
Current
-6 752%
Average
1.8%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
3 635.2%
=
Net Income
72.4m
/
Revenue
2m

Net Margin Across Competitors

PAVmed Inc
Glance View

Market Cap
9.8m USD
Industry
Health Care

PAVmed, Inc. is a commercial-stage technology medical device company, which engages in the commercialization of medical technologies. The company is headquartered in New York City, New York and currently employs 89 full-time employees. The company went IPO on 2016-07-27. The firm has four operating divisions. GI Health division includes EsoGuard, EsoCheck and EsoCure. EsoGuard and EsoCheck have been developed to provide non-invasive, patient-friendly screening test for the early detection of adenocarcinoma of the esophagus (EAC) and Barrett's Esophagus (BE), including dysplasia and related pre-cursors to EAC in patients with chronic gastroesophageal reflux (GERD). EsoCure is in development as an Esophageal Ablation Device with the intent to allow a clinician to treat dysplastic BE before it can progress to EAC. Minimally Invasive Interventions division offers CarpX, a minimally invasive surgical device for carpal tunnel syndrome. Infusion Therapy division includes PortIO, which is an implantable, intraosseous vascular access device, and NextFlo, which is a disposable, infusion platform technology that includes intravenous infusion sets and disposable infusion pumps.

PAVM Intrinsic Value
Not Available
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
3 635.2%
=
Net Income
72.4m
/
Revenue
2m
What is the Net Margin of PAVmed Inc?

Based on PAVmed Inc's most recent financial statements, the company has Net Margin of 3 635.2%.

Back to Top